GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinling Pharmaceutical Co Ltd (SZSE:000919) » Definitions » Days Sales Outstanding

Jinling Pharmaceutical Co (SZSE:000919) Days Sales Outstanding : 49.59 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinling Pharmaceutical Co Days Sales Outstanding?

Jinling Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥406 Mil. Jinling Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥747 Mil. Hence, Jinling Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 49.59.

The historical rank and industry rank for Jinling Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SZSE:000919' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.21   Med: 45.95   Max: 66.06
Current: 51.27

During the past 13 years, Jinling Pharmaceutical Co's highest Days Sales Outstanding was 66.06. The lowest was 38.21. And the median was 45.95.

SZSE:000919's Days Sales Outstanding is ranked better than
69.87% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.45 vs SZSE:000919: 51.27

Jinling Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2023 (38.83) to Mar. 2024 (49.59).


Jinling Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Jinling Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinling Pharmaceutical Co Days Sales Outstanding Chart

Jinling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.94 42.15 41.06 40.04 38.21

Jinling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.83 45.88 57.41 50.39 49.59

Competitive Comparison of Jinling Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Jinling Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinling Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinling Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jinling Pharmaceutical Co's Days Sales Outstanding falls into.



Jinling Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jinling Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (265.382 + 317.874) / 2 ) / 2785.738*365
=291.628 / 2785.738*365
=38.21

Jinling Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (317.874 + 493.505) / 2 ) / 746.53*365 / 4
=405.6895 / 746.53*365 / 4
=49.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinling Pharmaceutical Co  (SZSE:000919) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Jinling Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jinling Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinling Pharmaceutical Co (SZSE:000919) Business Description

Traded in Other Exchanges
N/A
Address
No. 238 Zhongyang Road, Jinling Pharmaceutical Building, Nanjing, Jiangsu, CHN, 210009
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.
Executives
Fan Jin Tian Director
Jia Ming Yi Executives
Li Quan Executives
Chen Sheng Executives
Xu Jun Yang Secretary Dong
Wang Yang Executives
Yin Jian Biao Executives
Li Jian Executives
Liang Yu Tang Directors, executives
Zhang Ning Executives
Li Chun Min Director
Sui Li Cheng Executives
Tang Wei Guo Directors, executives
Wang Suo Jin Executives
Shen Zhi Long Director

Jinling Pharmaceutical Co (SZSE:000919) Headlines

No Headlines